CH558365A - Antiinflammatory pyrazolidone-dione amino propoxy-indazole enolates - from the corresp-1H-indazole hydrochloride and suitable substd. pyrazolidine dione - Google Patents

Antiinflammatory pyrazolidone-dione amino propoxy-indazole enolates - from the corresp-1H-indazole hydrochloride and suitable substd. pyrazolidine dione

Info

Publication number
CH558365A
CH558365A CH736370A CH736370A CH558365A CH 558365 A CH558365 A CH 558365A CH 736370 A CH736370 A CH 736370A CH 736370 A CH736370 A CH 736370A CH 558365 A CH558365 A CH 558365A
Authority
CH
Switzerland
Prior art keywords
dione
indazole
enolates
corresp
pyrazolidone
Prior art date
Application number
CH736370A
Other languages
Italian (it)
Original Assignee
Roura Jose Gimbert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roura Jose Gimbert filed Critical Roura Jose Gimbert
Publication of CH558365A publication Critical patent/CH558365A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C07D231/34—Oxygen atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C07D231/36—Oxygen atoms with hydrocarbon radicals, substituted by hetero atoms, attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cpds. of formula (I): (where R, R2 are each H or lower alkyl, R2 is H or hydroxy, and R3 is O or two H atoms) are used as anti-inflammatories in the treatment of arthritis, rheumatism thrombophlebitis, inflammatory states and lumbago. The cpd. has also analgestic and antipyretic activity.
CH736370A 1969-05-16 1970-05-16 Antiinflammatory pyrazolidone-dione amino propoxy-indazole enolates - from the corresp-1H-indazole hydrochloride and suitable substd. pyrazolidine dione CH558365A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES69367372A ES367372A1 (en) 1969-05-16 1969-05-16 Procedure for the obtaining of new derivatives with anti-inflammatory action constituted by amense enzyns of the series of benzydamine with fenilbutazone, p-hydroxyphenyl butaczone and cetofenilbotazona. (Machine-translation by Google Translate, not legally binding)

Publications (1)

Publication Number Publication Date
CH558365A true CH558365A (en) 1975-01-31

Family

ID=8452785

Family Applications (1)

Application Number Title Priority Date Filing Date
CH736370A CH558365A (en) 1969-05-16 1970-05-16 Antiinflammatory pyrazolidone-dione amino propoxy-indazole enolates - from the corresp-1H-indazole hydrochloride and suitable substd. pyrazolidine dione

Country Status (2)

Country Link
CH (1) CH558365A (en)
ES (1) ES367372A1 (en)

Also Published As

Publication number Publication date
ES367372A1 (en) 1972-01-01

Similar Documents

Publication Publication Date Title
IT964503B (en) PROCEDURE FOR THE PROPHYLACTIC TREATMENT OF DEFICIENCIES OF IRON IN PIGS
CH558365A (en) Antiinflammatory pyrazolidone-dione amino propoxy-indazole enolates - from the corresp-1H-indazole hydrochloride and suitable substd. pyrazolidine dione
FI45660C (en) Process for the preparation of N-acyl derivatives of D-6-methyl and D-1,6-dimethyl-8-aminomethylergoline I for therapeutic use.
SE394850B (en) USE OF CERTAIN MARKAPTO-S-TRIAZINES FOR FIXING CERTAIN METAL IONES IN SOIL
FR2692M (en) New a-nor-b-homo-steroids which can be used in therapy, in particular as anti-inflammatory agents.
CA506413A (en) Therapeutic agents used in the treatment of pathogenic organisms
FR1456M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
CA561523A (en) Treatment of water with bactericides
AU227287B2 (en) Improvements in or relating to the treatment of ferrous metal surfaces
CA623357A (en) Treatment of steel surfaces
FR1322726A (en) Improvement in the nitriding of steels
FR37M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
AU236340B2 (en) Improvements in or relating tothe treatment of sewage
FR1510M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
AU250643B2 (en) Treatment of ferrous metal surfaces
AU3602858A (en) Improvements in or relating to the treatment of ferrous metal surfaces
AT193416B (en) Austenitic nickel-chromium-manganese steel and its heat treatment
AU252457B2 (en) Improvements in or relating to the manufacture of cast iron baths
FR2210388A1 (en) 4-Phenoxy-3-hydroxy-butyramidines - as agents for treating cardiac rhythm disorders
FR2982M (en) Therapeutic agent promoting the biosynthesis of proteins in the body.
FR2105099A1 (en) Dinucleotide antimetabolites - 3-diazoacetyl or chloroacetyl pyridine adenine dinucleotides
AU5966660A (en) Improvements in or relating tothe treatment of sewage
AU6471660A (en) Treatment of ferrous metal surfaces
FR2051M (en) New tetracosapeptide of the formula l - seryl - l -tyrosyl - l - seryl - l - methionyl - l - glutamyl - l - histidyl - l - phenylalanyl - l - arginyl - l - tryptophyl - glycyl - l - lysyl - l - prolyl - l - valyl - glycyl - l - lysyl - l - lysyl - l - arginyl - l - arginyl - l - prolyl - l - valyl - l - lysyl - l - valyl - l - tyrosyl - l - proline and its usable salts in therapy.
FR1457M (en) New drug in particular for the treatment of hypophyseal follicle stimulating hyperactivity.

Legal Events

Date Code Title Description
PL Patent ceased